Clinical trial / 1997
Vitamin E supplementation, particularly at 200 mg/d, enhanced clinically relevant indexes of T-cell-mediated function in healthy elderly adults.
A randomized, double-blind, placebo-controlled study evaluated the effect of vitamin E supplementation (60, 200, or 800 mg/d vs. placebo) for 235 days in 88 healthy elderly subjects. Subjects consuming 200 mg/d showed a 65% increase in DTH and a 6-fold increase in antibody titer to hepatitis B compared to placebo (17% and 3-fold), 60-mg/d (41% and 3-fold), and 800-mg/d (49% and 2.5-fold) groups, as well as a significant increase in tetanus antibody titer. Vitamin E had no effect on diphtheria antibody titer, immunoglobulin levels, T- and B-cell counts, or autoantibody levels.
- Study type
- Randomized, double-blind, placebo-controlled trial
- Who was studied
- 88 free-living, healthy subjects at least 65 years of age
- What was measured
- Delayed-type hypersensitivity skin response (DTH), vaccine antibody responses, and autoantibody levels
THE PAPER
Vitamin E supplementation and in vivo immune response in healthy elderly subjects. A randomized controlled trial.
Meydani SN, Meydani M, Blumberg JB, Leka LS, Siber G, Loszewski R, Thompson C, Pedrosa MC, Diamond RD, Stollar BD. JAMA, 1997.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.